advertisement

Oculus

11.5.2 Topical (20)

Showing records 1 to 20

Display all abstracts in classification 11.5.2 Topical

Search within classification 11.5.2 Topical
81169 Osmoprotectants in Hybrid Liposome/HPMC Systems as Potential Glaucoma Treatment
Gómez-Ballesteros M
Polymers 2019; 11:
81199 Designing of a pH-Triggered Carbopol®/HPMC In Situ Gel for Ocular Delivery of Dorzolamide HCl: In Vitro, In Vivo, and Ex Vivo Evaluation
Kouchak M
AAPS PharmSciTech 2019; 20: 210
80450 Direct and crossover effects of brinzolamide, betaxolol, and latanoprost on choroidal thickness
Okutucu M
Cutaneous and Ocular Toxicology 2019; 38: 196-200
81416 Efficacy and Safety of Brinzolamide as Add-On to Prostaglandin Analogues or β-Blocker for Glaucoma and Ocular Hypertension: A Systematic Review and Meta-Analysis
Liu Y
Frontiers in pharmacology 2019; 10: 679
80713 Effect of Topical Hypotensive Medications for Preventing Intraocular Pressure Increase after Cataract Surgery in Eyes with Glaucoma
Hayashi K
American Journal of Ophthalmology 2019; 205: 91-98
81199 Designing of a pH-Triggered Carbopol®/HPMC In Situ Gel for Ocular Delivery of Dorzolamide HCl: In Vitro, In Vivo, and Ex Vivo Evaluation
Mahmoodzadeh M
AAPS PharmSciTech 2019; 20: 210
81416 Efficacy and Safety of Brinzolamide as Add-On to Prostaglandin Analogues or β-Blocker for Glaucoma and Ocular Hypertension: A Systematic Review and Meta-Analysis
Zhao J
Frontiers in pharmacology 2019; 10: 679
80713 Effect of Topical Hypotensive Medications for Preventing Intraocular Pressure Increase after Cataract Surgery in Eyes with Glaucoma
Yoshida M
American Journal of Ophthalmology 2019; 205: 91-98
81169 Osmoprotectants in Hybrid Liposome/HPMC Systems as Potential Glaucoma Treatment
López-Cano JJ
Polymers 2019; 11:
80450 Direct and crossover effects of brinzolamide, betaxolol, and latanoprost on choroidal thickness
Fındık H
Cutaneous and Ocular Toxicology 2019; 38: 196-200
80713 Effect of Topical Hypotensive Medications for Preventing Intraocular Pressure Increase after Cataract Surgery in Eyes with Glaucoma
Sato T
American Journal of Ophthalmology 2019; 205: 91-98
81199 Designing of a pH-Triggered Carbopol®/HPMC In Situ Gel for Ocular Delivery of Dorzolamide HCl: In Vitro, In Vivo, and Ex Vivo Evaluation
Farrahi F
AAPS PharmSciTech 2019; 20: 210
80450 Direct and crossover effects of brinzolamide, betaxolol, and latanoprost on choroidal thickness
Arslan MG
Cutaneous and Ocular Toxicology 2019; 38: 196-200
81169 Osmoprotectants in Hybrid Liposome/HPMC Systems as Potential Glaucoma Treatment
Bravo-Osuna I
Polymers 2019; 11:
81416 Efficacy and Safety of Brinzolamide as Add-On to Prostaglandin Analogues or β-Blocker for Glaucoma and Ocular Hypertension: A Systematic Review and Meta-Analysis
Zhong X
Frontiers in pharmacology 2019; 10: 679
81169 Osmoprotectants in Hybrid Liposome/HPMC Systems as Potential Glaucoma Treatment
Herrero-Vanrell R
Polymers 2019; 11:
80713 Effect of Topical Hypotensive Medications for Preventing Intraocular Pressure Increase after Cataract Surgery in Eyes with Glaucoma
Manabe SI
American Journal of Ophthalmology 2019; 205: 91-98
81416 Efficacy and Safety of Brinzolamide as Add-On to Prostaglandin Analogues or β-Blocker for Glaucoma and Ocular Hypertension: A Systematic Review and Meta-Analysis
Wei Q
Frontiers in pharmacology 2019; 10: 679
81169 Osmoprotectants in Hybrid Liposome/HPMC Systems as Potential Glaucoma Treatment
Molina-Martínez IT
Polymers 2019; 11:
81416 Efficacy and Safety of Brinzolamide as Add-On to Prostaglandin Analogues or β-Blocker for Glaucoma and Ocular Hypertension: A Systematic Review and Meta-Analysis
Huang Y
Frontiers in pharmacology 2019; 10: 679

Issue 20-3

Select Issue


advertisement

Oculus